Safety and Management of Targeted Therapies for Relapsed/Refractory Chronic Lymphocytic Leukemia.
Saved in:
| Title: | Safety and Management of Targeted Therapies for Relapsed/Refractory Chronic Lymphocytic Leukemia. |
|---|---|
| Authors: | Ailawadhi S; Division of Hematology-Oncology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL, 32224, USA. Ailawadhi.Sikander@mayo.edu., Omercikoglu E; Division of Hematology-Oncology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL, 32224, USA., Paulus A; Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, USA., Parrondo RD; Division of Hematology-Oncology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL, 32224, USA., Chanan-Khan AA; Division of Hematology-Oncology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL, 32224, USA.; Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, USA. |
| Source: | Drug safety [Drug Saf] 2026 Jul 15. Date of Electronic Publication: 2026 Jul 15. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1942 (Electronic) Linking ISSN: 01145916 NLM ISO Abbreviation: Drug Saf Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
